13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04832269
(ClinicalTrials.gov)
October 19, 202018/2/2021Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and BehaviourEffects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone (MP) During Pregnancy on Offspring Cognitive Function, Stress Sensitivity, Behaviour and Functional and Structural Brain DevelopmentMultiple SclerosisOther: Exposure to methylprednisolone during pregnancyJena University HospitalRuhr University of Bochum;Interdisciplinary Center of Clinical Research of the Medical Faculty Jena;Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyRecruiting8 Years18 YearsAll80Germany